Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
10.1038/nchembio.2239 69
Ultimately, your supplementation plan should be based on individualized, evidence-based care
10.3390/cancers14112608 Cancers
Best For PTD-DBM is most promising for individuals with androgenetic alopecia (male or female pattern hair loss) who want a targeted treatment that addresses DHT-related follicle miniaturization without systemic hormonal effects
Phase 3 Status: TRIUMPH Program (May 2026 Snapshot) The TRIUMPH program is the set of large Phase 3 trials that will form the core of Eli Lillys eventual FDA submission
According to statistics, approximately 9.4 million people worldwide had PD in 2020, and the incidence is rising with global aging, especially in high-income and some middle-income countries (6, 7)
US$ 24.39
US$ 26.35
US$ 24.38
US$ 22.28
US$ 25.14
US$ 29.77
US$ 24.89
US$ 21.42
